Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Environment
Illumina To Allow Nonhuman Sequencing
by Ann M. Thayer
October 12, 2015
| A version of this story appeared in
Volume 93, Issue 40
Illumina has extended the usage rights of its high-throughput next-generation gene sequencing systems to allow sequencing of nonhuman species. The firm hopes the move will expand the market for very large scale sequencing in areas such as agricultural research and model organisms for pharma R&D. The Wellcome Trust Sanger Institute, one of Illumina’s earliest customers for its HiSeq X Ten system, intends to conduct whole-genome sequencing projects on organisms of importance for public health, such as malaria and other pathogens.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter